Matches in Wikidata for { <http://www.wikidata.org/entity/Q43917817> ?p ?o ?g. }
- Q43917817 description "2013 nî lūn-bûn" @default.
- Q43917817 description "2013年の論文" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年学术文章" @default.
- Q43917817 description "2013年學術文章" @default.
- Q43917817 description "2013年學術文章" @default.
- Q43917817 description "2013年學術文章" @default.
- Q43917817 description "2013年學術文章" @default.
- Q43917817 description "2013年學術文章" @default.
- Q43917817 description "2013년 논문" @default.
- Q43917817 description "article científic" @default.
- Q43917817 description "article scientific" @default.
- Q43917817 description "article scientifique" @default.
- Q43917817 description "articol științific" @default.
- Q43917817 description "articolo scientifico" @default.
- Q43917817 description "artigo científico" @default.
- Q43917817 description "artigo científico" @default.
- Q43917817 description "artigo científico" @default.
- Q43917817 description "artikel ilmiah" @default.
- Q43917817 description "artikull shkencor" @default.
- Q43917817 description "artikulong pang-agham" @default.
- Q43917817 description "artykuł naukowy" @default.
- Q43917817 description "artículo científico publicado en 2013" @default.
- Q43917817 description "artículu científicu espublizáu en 2013" @default.
- Q43917817 description "bilimsel makale" @default.
- Q43917817 description "bài báo khoa học" @default.
- Q43917817 description "naučni članak" @default.
- Q43917817 description "scienca artikolo" @default.
- Q43917817 description "scientific article published on 17 January 2013" @default.
- Q43917817 description "scientific article published on 17 January 2013" @default.
- Q43917817 description "scientific article published on 17 January 2013" @default.
- Q43917817 description "teaduslik artikkel" @default.
- Q43917817 description "tieteellinen artikkeli" @default.
- Q43917817 description "tudományos cikk" @default.
- Q43917817 description "vedecký článok" @default.
- Q43917817 description "vetenskaplig artikel" @default.
- Q43917817 description "videnskabelig artikel" @default.
- Q43917817 description "vitenskapelig artikkel" @default.
- Q43917817 description "vitskapeleg artikkel" @default.
- Q43917817 description "vědecký článek" @default.
- Q43917817 description "wetenschappelijk artikel" @default.
- Q43917817 description "wissenschaftlicher Artikel" @default.
- Q43917817 description "επιστημονικό άρθρο" @default.
- Q43917817 description "мақолаи илмӣ" @default.
- Q43917817 description "наукова стаття, опублікована в січні 2013" @default.
- Q43917817 description "научна статия" @default.
- Q43917817 description "научная статья" @default.
- Q43917817 description "научни чланак" @default.
- Q43917817 description "научни чланак" @default.
- Q43917817 description "מאמר מדעי" @default.
- Q43917817 description "مقالة علمية نشرت في 17 يناير 2013" @default.
- Q43917817 description "১৭ জানুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43917817 description "บทความทางวิทยาศาสตร์" @default.
- Q43917817 description "სამეცნიერო სტატია" @default.
- Q43917817 name "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 name "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 type Item @default.
- Q43917817 label "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 label "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 prefLabel "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 prefLabel "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 P1433 Q43917817-FEF01C5D-53AD-4AF0-8F11-964A45DBF6B1 @default.
- Q43917817 P1476 Q43917817-8DDE938A-A0AE-4BB7-BCBC-F7053FA3A139 @default.
- Q43917817 P2093 Q43917817-383FA21F-061F-4F38-9333-C7A75DFD5763 @default.
- Q43917817 P2093 Q43917817-64C1BE65-5C5E-451A-B297-EED4E443EA89 @default.
- Q43917817 P2093 Q43917817-6D7DB7C2-731C-43A4-8EC9-6C0C1985F320 @default.
- Q43917817 P2093 Q43917817-83600A9A-2B3B-42D1-AB2D-D0598A6982D6 @default.
- Q43917817 P2093 Q43917817-D27155C3-0B54-47FA-831F-6214405EB438 @default.
- Q43917817 P2093 Q43917817-DE8C872A-B35B-4B26-831F-795C80673248 @default.
- Q43917817 P2093 Q43917817-E79AD5E1-2754-45A3-91D0-6CEC7CCB4041 @default.
- Q43917817 P2860 Q43917817-0751C310-A20A-4BE2-8D3B-36980709B9A8 @default.
- Q43917817 P2860 Q43917817-2958F559-F266-43AE-BF95-31C423528D68 @default.
- Q43917817 P2860 Q43917817-5B404EDD-A1B5-44D2-AC9C-E85410DF30C5 @default.
- Q43917817 P2860 Q43917817-750AC594-F46E-4750-A1A6-F1D420ABB789 @default.
- Q43917817 P2860 Q43917817-D7B37462-EF24-4AD3-9E9F-B2605D328E43 @default.
- Q43917817 P2860 Q43917817-E1081124-FD9D-4300-ADA3-ED4171851B2E @default.
- Q43917817 P2860 Q43917817-F693533C-90A5-4401-A340-C745C37765C4 @default.
- Q43917817 P304 Q43917817-D4B283CF-5085-4DBB-9CBC-BA539B852111 @default.
- Q43917817 P31 Q43917817-49BB9624-C0A4-4A4F-BFAB-29E1F810444F @default.
- Q43917817 P356 Q43917817-D0D8D7A4-5CD9-4E7B-81CD-6D4E74372083 @default.
- Q43917817 P407 Q43917817-08326DFD-7744-4F9A-A76C-D25A598EB025 @default.
- Q43917817 P433 Q43917817-FC3CC20F-00F7-479D-A538-DCCAE4514B0A @default.
- Q43917817 P478 Q43917817-96BF2C42-16F8-401E-B729-2515DB0E1FB1 @default.
- Q43917817 P577 Q43917817-631256F8-5977-47FD-B84B-70589D8A57E7 @default.
- Q43917817 P5875 Q43917817-5E755345-31D7-4547-99E4-477125B78D32 @default.
- Q43917817 P698 Q43917817-4F81D897-C18D-4116-8633-C691B3E05CA4 @default.
- Q43917817 P921 Q43917817-420738FC-1EF8-419A-B479-5C57BF77C020 @default.
- Q43917817 P921 Q43917817-BA346B0E-B547-4819-ACDC-0EC47D95EA6E @default.
- Q43917817 P921 Q43917817-DE334461-70CB-496F-9AD0-076D6CF2529A @default.
- Q43917817 P356 000346328 @default.
- Q43917817 P698 23328486 @default.
- Q43917817 P1433 Q2016300 @default.
- Q43917817 P1476 "A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan" @default.
- Q43917817 P2093 "Adrienne Groman" @default.
- Q43917817 P2093 "Ahmad A Fora" @default.
- Q43917817 P2093 "Greg Wilding" @default.